4-Bromobenzoic acid:Exports & Compliance White Paper 2026

I. Executive Summary

4-Bromobenzoic acid (CAS 586-76-5, C7H5BrO2, molecular weight 201.02) is a high-melting, crystalline brominated aromatic carboxylic acid whose commercial value lies almost entirely in its function as a bifunctional building block: the aryl bromide serves as the electrophilic partner in palladium-catalysed cross-coupling, while the carboxylic acid provides a handle for amidation, esterification and salt formation. Demand therefore tracks the health of pharmaceutical and electronic-materials pipelines rather than any single end product.

Supply is built overwhelmingly on the oxidation of 4-bromotoluene, with para selectivity inherited from the bromination of toluene rather than achieved later, because the carboxylic acid group is strongly deactivating and meta-directing. Cobalt-manganese-bromide catalytic air oxidation in acetic acid dominates tonnage production, while Sandmeyer diazotisation of 4-aminobenzoic acid, Grignard carboxylation of 1,4-dibromobenzene and haloform oxidation of 4-bromoacetophenone are retained for projects requiring lower isomer or metal content.

The commercial qualification gates in 2026 are isomer purity, residual metal and halogen control, and dust-safety management. Buyers serving regulated pharmaceutical customers must control palladium as a Class 2B elemental impurity under ICH Q3D, assess residual brominated species under ICH M7, and demonstrate REACH or TSCA compliance with coherent dust-exposure and dust-explosion controls. This paper sets out the chemistry, market, compliance and logistics perimeter for professional sourcing teams.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

The product is a white to off-white crystalline solid melting in the 254 to 256 degrees Celsius range with partial sublimation, sparingly soluble in cold water but readily soluble in hot water, alcohols, ethers and polar aprotic solvents. Its acidity, with a pKa close to 4.0, is slightly stronger than benzoic acid because the para bromine withdraws electron density inductively. The combination of a very high melting point, low vapour pressure and negligible flammability means that physical hazards are dominated by dust rather than by fire, and that purification is almost always achieved by crystallisation rather than distillation.

• Aryl bromide reactivity in cross-coupling: The carbon-bromine bond undergoes oxidative addition to palladium(0) far more readily than the corresponding chloride, which makes the compound a reliable electrophilic partner in Suzuki-Miyaura, Buchwald-Hartwig, Sonogashira, Heck and cyanation chemistry. This is the single reason the molecule is specified: it installs a para-carboxylated aryl fragment into biaryl, arylamine, arylalkyne and aryl nitrile targets in one predictable step.
• Carboxylic acid derivatisation behaviour: The acid group is converted cleanly to acid chlorides, esters, amides, hydrazides and metal carboxylates, and it can act as a directing or anchoring group in metal-organic framework and coordination chemistry. Electron withdrawal by bromine also raises the acidity slightly and influences crystal habit and solubility, which is why polymorph and particle-size control matter for downstream filtration and drying performance.

2.2 Synthesis and Manufacturing Technologies

Industrial practice separates into a tonnage oxidation route and a set of higher-purity routes. The oxidation route brominates toluene to a para-rich bromotoluene mixture, isolates the para isomer by fractional distillation and crystallisation, then oxidises the methyl group. Alternative routes bypass bromotoluene entirely and are preferred when isomer or catalyst-metal specifications are unusually tight, or when the project originates in a pharmaceutical development pipeline where route-defining impurity profiles are frozen early.

• Catalytic oxidation of 4-bromotoluene: The Amoco-type liquid-phase oxidation uses a cobalt-manganese-bromide catalyst system in acetic acid under air or oxygen at elevated temperature and pressure, with permanganate, nitric acid or dichromate variants retained at smaller scale. Critical control points are complete methyl conversion, suppression of aldehyde and benzyl bromide intermediates, and removal of catalyst metals, since residual cobalt, manganese and bromide all carry into the isolated acid.
• Sandmeyer, Grignard and haloform alternatives: Diazotisation of 4-aminobenzoic acid followed by copper bromide substitution gives high regiochemical purity, Grignard formation from 1,4-dibromobenzene and carboxylation with carbon dioxide avoids isomer formation altogether, and haloform oxidation of 4-bromoacetophenone offers a clean laboratory and pilot route. Each generates a distinct impurity signature, so route declaration in the regulatory dossier is a genuine compliance decision rather than a formality.

2.3 Core Application Matrix

• Pharmaceutical intermediate: The compound is a standard starting material for biaryl carboxylic acids, arylamides and aryl nitriles found in kinase inhibitor, metabolic disease and central nervous system development programmes. It is purchased to GMP-adjacent specifications with defined impurity profiles, residual metal limits and full route traceability, and is frequently supplied under a custom-synthesis agreement rather than from catalogue stock.
• Electronic and advanced materials: Brominated aromatic carboxylic acids are used in liquid-crystal monomers, organic light-emitting diode and organic semiconductor intermediates, photoactive materials and, through their metal carboxylates, in framework and coordination materials. These customers prioritise isomer purity, trace metal content and particle characteristics over price, and often require sub-ppm metal screening.
• Agrochemicals, dyes and analytical use: The molecule serves as an intermediate for crop-protection active ingredients and speciality dyes and pigments, and is used as a reference and derivatisation reagent in analytical chemistry. It also functions as a model substrate in catalyst screening and methodology development, which sustains steady small-pack demand from research and CRO customers.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Three demand engines define the market. Pharmaceutical and CDMO pipelines continue to favour aryl bromide building blocks because coupling chemistry is predictable and scalable, so development-stage volumes convert into commercial demand with a multi-year lag. Second, organic electronics and liquid-crystal material production in East Asia is growing and requires very high purity brominated aromatics. Third, agrochemical and speciality dye reformulation sustains a stable technical-grade base that absorbs capacity during pharmaceutical downturns.

3.2 Capacity Distribution and Export Flows

China dominates capacity, with production concentrated in the Shandong bromine belt and in the Jiangsu and Zhejiang aromatic intermediates cluster, supported by domestic brine-bromine extraction and by integrated toluene and acetic acid supply. India supplies growing volumes from Gujarat and Maharashtra, where custom synthesis and API intermediate manufacturers combine domestic bromine imports with strong process chemistry capability. Japan and Western Europe hold smaller but strategically important high-purity and electronic-grade capacity, with Japan particularly strong in sub-ppm metal control and Europe in reagent and catalogue distribution, while North America remains largely import-dependent.

3.3 Market Bifurcation and Pricing Dynamics

Pricing is unusually sensitive to bromine, which is a concentrated global market and transmits volatility quickly into brominated intermediate offers, and secondarily to toluene and acetic acid costs. The market is bifurcated between technical grade sold on assay alone and pharmaceutical or electronic grade sold on isomer profile, residual palladium, halide and metal content, and documentation depth. Buyers who purchase technical grade for regulated use consistently underestimate the cost of retrospective impurity qualification, which usually exceeds the original price differential several times over.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

Compliance for 4-bromobenzoic acid operates on two levels. As a substance it must be registered and classified for industrial supply under REACH and listed as active under TSCA, neither of which is onerous for a company with a competent regulatory function. As a pharmaceutical or electronic input it must additionally satisfy customer impurity science: elemental impurity risk assessment, residual solvent control, and genotoxic impurity assessment under ICH guidance, all of which must be documented before the material can enter a validated process.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

• REACH registration and CLP self-classification: The substance is registered under REACH and supplied with an extended safety data sheet where exposure scenarios are required. It has no harmonised CLP entry, so suppliers self-classify and notifications vary, with acute oral toxicity, skin and eye irritation and respiratory tract effects commonly notified. Buyers must reconcile these differences in their own downstream risk assessment and must align with the only representative route where a non-EU manufacturer is involved.
• Brominated compound scrutiny and waste rules: Although the substance is not a persistent organic pollutant or a brominated flame retardant, brominated aromatics attract elevated scrutiny, and halogenated process waste is expensive to dispose of. European customers routinely request adsorbable organic halogen data on effluents, evidence of bromine recovery or destruction, and confirmation that the material is not intended for use restricted under the POP Regulation or relevant Annex XVII entries.

4.2 North American Market: TSCA, EPA, and FDA Regulations

• TSCA inventory status and reporting: 4-Bromobenzoic acid is listed as active on the TSCA Inventory, so import needs no premanufacture notice, but importers must still provide Section 13 import certification, monitor Chemical Data Reporting thresholds and confirm that the specific grade and any associated impurity profile remain within the scope of the listing. Inactive or partial designations on close analogues are a recurring source of customs delay.
• FDA-facing quality expectations: Where the material enters an API process, the sponsor must control elemental impurities under ICH Q3D, residual solvents under ICH Q3C, and mutagenic impurities under ICH M7, and must declare the route and specification in the regulatory submission. Palladium, as a Class 2B elemental impurity, is the element most likely to drive specification design when coupling catalysts are used downstream of the intermediate.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

Brominated intermediate manufacturing carries an environmental profile that customers now audit in detail. Bromine production is energy and resource intensive, oxidation routes generate acetic acid and metal-bearing mother liquors, and halogenated organic waste incurs high disposal cost. Producers that recover bromine values, recycle acetic acid, and treat halogenated effluents to low adsorbable organic halogen levels convert an ESG liability into a demonstrable qualification advantage.

5.1 Carbon Footprint and Circular Economy

Cradle-to-gate emissions are driven by upstream bromine extraction, acetic acid production and the energy demand of high-temperature oxidation and multiple crystallisation and drying steps. Practical reduction levers include solvent and acetic acid recovery loops, catalytic rather than stoichiometric oxidation, heat integration between reactor and crystalliser, and replacement of fossil steam with recovered heat. Buyers assessing Scope 3 emissions should request product-level footprints aligned to ISO 14067 or the GHG Protocol Product Standard and should confirm whether waste treatment is inside the declared boundary.

5.2 Sustainable Sourcing and Traceability

Traceability expectations now reach back to the bromine source and forward to metal catalyst custody. Buyers increasingly ask for documented brine or bromine origin, evidence that process metals are recovered rather than discharged, and chain-of-custody documentation for recycled solvent streams. ISO 9001 and ISO 14001 certification, third-party responsible-care or EcoVadis auditing, and batch-level traceability from bromination through oxidation to crystallisation are becoming standard tender requirements rather than differentiators in Western pharmaceutical supply chains.

VI. Supply Chain Resilience and Export Logistics

4-Bromobenzoic acid is, from a transport standpoint, a benign crystalline solid, which is precisely why it is often mishandled. The real risks are moisture pickup and caking, contamination from shared equipment, and combustible dust hazards during charging and milling. A resilient supply programme therefore focuses on packaging integrity, dust-safety documentation and dual-source qualification rather than on temperature-controlled freight.

6.1 Packaging Standards and Moisture/Contamination Control

• Moisture barrier and particle integrity: Material should be packed in polyethylene-lined fibre drums or woven bags with an inner moisture barrier, sealed with desiccant where long sea transit is expected, and palletised to prevent bag rupture. Because the product is high-melting and crystallises with defined habit, ingress of moisture or solvent vapour can cause caking and change filtration behaviour at the customer, so water content and loss on drying should be specified and tested.
• Cross-contamination and cleaning control: Multi-purpose fine-chemical plants must demonstrate validated cleaning between campaigns, particularly where brominated, iodinated or metal-catalysed products share equipment. Buyers should require dedicated or campaign-dedicated crystallisation and drying equipment for pharmaceutical grades, retain samples from every lot, and insist on change-control notification for any route, catalyst or solvent substitution.

6.2 Dangerous Goods Identification and Transit Protocols

Most safety data sheets classify 4-bromobenzoic acid as not dangerous for transport under IMDG, ADR, RID and IATA, so it ships as a general cargo solid in bags or drums, normally by sea in containerised lots with moisture-protective packaging and by road or rail for regional distribution. The operational hazard that does require formal control is combustible dust: producers should determine explosibility parameters such as Kst, maximum explosion pressure and minimum ignition energy, classify zones under ATEX or the NFPA combustible dust standards, and use grounded, dust-tight transfer equipment and local exhaust ventilation.

VII. Enterprise Global Expansion Strategy Guide

Sustainable advantage in brominated aromatic intermediates comes from impurity science and regulatory support rather than from scale alone. Suppliers who publish credible impurity profiles, control metals proactively and hold the documentation that regulated customers need will win long-term agreements even at a premium.

1. Engineer the impurity profile, not just the assay: Invest in isomer-selective synthesis or crystallisation, ICP-MS screening for cobalt, manganese, copper and palladium, and validated methods for residual bromotoluene and dibrominated species. Being able to commit to a palladium limit consistent with ICH Q3D Class 2B expectations is often the single factor that wins pharmaceutical qualification.
2. Build a bromine and metal recovery story: Halogenated waste disposal cost and adsorbable organic halogen discharge limits are tightening in China, India and the EU simultaneously. Producers who recover bromine values, recycle acetic acid and solvent, and document low halogen load in effluent gain both a cost advantage and a defensible ESG position that survives customer audit.
3. Dual-source across regions and protect the route: Qualify at least one Chinese and one Indian or Japanese source so that bromine price shocks, environmental inspection cycles or logistics disruption do not halt programmes. Treat route, catalyst and solvent as registered parameters under change control, because unannounced route changes invalidate downstream impurity risk assessments and regulatory filings.

VIII. Conclusion

4-Bromobenzoic acid will remain a structurally demanded building block because the chemistry it enables, palladium-catalysed coupling at a para-carboxylated aryl bromide, is central to how modern pharmaceutical and electronic materials are assembled. Demand is diversified across pharma, agrochemical, dye and organic electronics outlets, and is anchored in East Asian capacity with growing Indian participation, giving buyers a genuinely competitive supply base.

The value in this market has shifted decisively from molecule to documentation. Regioisomeric purity, palladium and metal control, ICH Q3D and M7 justification, bromine and halogen waste management, and dust-safety discipline are the factors that separate a qualified supplier from a commodity trader. Organisations that build their sourcing specification around those factors will secure supply through the next bromine price cycle; those that buy on assay alone will not.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global 4-Bromobenzoic acid Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global 4-Bromobenzoic acid supply chain:

• China: Bromine Belt and Aromatics Cluster: Shandong combines domestic brine-bromine extraction with bromination capacity, while Jiangsu and Zhejiang host the oxidation, crystallisation and custom-synthesis plants that convert bromotoluene into finished acid and derivatives. Chinese suppliers set the global technical-grade price floor and are steadily moving into pharmaceutical grades, though buyers should audit isomer control, metal screening and halogenated waste handling before qualification.
• India: Custom Synthesis and API Intermediate Hub: Gujarat and Maharashtra host custom synthesis and API intermediate manufacturers that combine imported bromine with strong process chemistry capability, serving both multinational pharmaceutical development pipelines and domestic agrochemical producers. Indian suppliers compete on route development, documentation support and flexible campaign sizing rather than on commodity price, and many operate to ICH-aligned quality systems.
• Japan and the European Union: High-Purity and Electronic-Grade Specialists: Japanese producers lead in sub-ppm metal control, particle engineering and consistency for organic electronics and liquid-crystal applications, while European participants supply reagent, catalogue and analytical grades with mature REACH documentation. These sources are preferred where isomer purity, trace metal limits and documentation depth outweigh price considerations.